SCHEMBL6038024

SCHEMBL6038024

CN(C)c1ccc(C(=O)NCCCCCNC(=O)CSc2ccc(N)cc2)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HDAC1 Q13547 11/20 0.61
▸ HDAC10 Q969S8 10/20 0.61
▸ HDAC6 Q9UBN7 10/20 0.61
▸ HDAC8 Q9BY41 9/20 0.61
▸ HDAC2 Q92769 8/20 0.61
▸ KMT2A Q03164 2/20 0.58
▸ HDAC3 O15379 8/20 0.57
▸ HDAC11 Q96DB2 7/20 0.57
▸ HDAC4 P56524 6/20 0.57
▸ HDAC7 Q8WUI4 6/20 0.57
▸ HDAC9 Q9UKV0 6/20 0.57
▸ HDAC5 Q9UQL6 6/20 0.57
▸ LTA4H P09960 1/20 0.57
▸ NAMPT P43490 1/20 0.48
▸ HTT P42858 1/20 0.46
▸ HSD17B10 Q99714 1/20 0.46
▸ KDM4E B2RXH2 1/20 0.45
▸ MAPT P10636 1/20 0.45
▸ RAB9A P51151 1/20 0.45
▸ LMNA P02545 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6038025 0.85 HDAC1 (0.57) HDAC1HDAC10HDAC6HDAC8HDAC2
SCHEMBL12727089 0.78 HDAC1 (0.77) HDAC1HDAC10HDAC6HDAC8HDAC2
SCHEMBL1004150 0.76 HDAC1 (1.00) HDAC1HDAC10HDAC6HDAC8HDAC2
SCHEMBL1366970 0.76 HDAC1 (1.00) HDAC1HDAC10HDAC6HDAC8HDAC2
SCHEMBL16127495 0.76 HDAC1 (0.74) HDAC1HDAC10HDAC6HDAC8HDAC2
SCHEMBL10536163 0.75 MAPK1 (0.65) HDAC1HDAC10HDAC6HDAC8HDAC2
SCHEMBL14097385 0.75 MAPK1 (0.65) HDAC1HDAC10HDAC6HDAC8HDAC2
SCHEMBL9419699 0.75 MAPK1 (0.65) HDAC1HDAC10HDAC6HDAC8HDAC2
SCHEMBL1366844 0.75 HDAC1 (1.00) HDAC1HDAC10HDAC6HDAC8HDAC2
SCHEMBL17404991 0.75 HDAC1 (0.76) HDAC1HDAC10HDAC6HDAC8HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060264415-A1 Inhibitors of histone deacetylase METHYLGENE INC. 2006-11-23 — — US claimed
US-20060264415-A1 Inhibitors of histone deacetylase METHYLGENE INC. 2006-11-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060264415-A1 Inhibitors of histone deacetylase HDAC1, HDAC3, HDAC11 HDAC1 1/4885HDAC10 9/4885HDAC6 17/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback